⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

December 9, 2008Journal of Clinical Oncology

Patient With Malignant Paraganglioma Responding to the Multikinase Inhibitor Sunitinib Malate

View Full Paper

Ask AI

Bookmark

Share

Abstract

Noah M. Hahn, Maria Reckova, Liang Cheng, Lee Ann Baldridge, Oscar W. Cummings, and Christopher J. Sweeney

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hahn et al. (2008) studied this question.

synapsesocial.com/papers/6a89569e47b10e0a7dd438bb https://doi.org/10.1200/jco.2008.19.9380

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Neuroendocrine Secretory Protein-55 (NESP-55) Expression Discriminates Pancreatic Endocrine Tumors and Pheochromocytomas From Gastrointestinal and Pulmonary CarcinoidsOriginal Research · 2004 · 48 citations
2Benign Paragangliomas: Clinical Presentation and Treatment Outcomes in 236 PatientsCohort Study · 2001 · 610 citations
3Extraadrenal Paragangliomas of the Body: Imaging FeaturesOriginal Research · 2006 · 256 citations
4Cervical paraganglioma—A case report and review of all cases reported to the Manchester Children's Tumour Registry 1954–2004Registry Study · 2006 · 9 citations
5Gross <i>SDHB</i> deletions in patients with paraganglioma detected by multiplex PCR: A possible hot spot?Original Research · 2005 · 77 citations